289 related articles for article (PubMed ID: 26891375)
21. Guideline for the diagnosis and management of myelofibrosis.
Reilly JT; McMullin MF; Beer PA; Butt N; Conneally E; Duncombe A; Green AR; Michaeel NG; Gilleece MH; Hall GW; Knapper S; Mead A; Mesa RA; Sekhar M; Wilkins B; Harrison CN;
Br J Haematol; 2012 Aug; 158(4):453-71. PubMed ID: 22651893
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic myelofibrosis: pathogenesis to treatment.
Reilly JT
Hematol Oncol; 2006 Jun; 24(2):56-63. PubMed ID: 16477581
[TBL] [Abstract][Full Text] [Related]
23. Myelofibrosis and rapid thrombocytolysis. A case report.
Kutti J; Bergström AL; Ridell B
Acta Med Scand; 1977; 201(3):249-55. PubMed ID: 848365
[TBL] [Abstract][Full Text] [Related]
24. Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials.
Stein BL
Curr Hematol Malig Rep; 2021 Oct; 16(5):483-489. PubMed ID: 34499329
[TBL] [Abstract][Full Text] [Related]
25. [Investigation and treatment of prefibrotic/early primary myelofibrosis. A case study].
Magyari F; Bedekovics J; Décsy J; Ilonczai P; Illés Á; Simon Z
Orv Hetil; 2018 Apr; 159(15):603-609. PubMed ID: 29631428
[TBL] [Abstract][Full Text] [Related]
26. Long-term results of prednisone treatment for the anemia of myelofibrosis.
Hernández-Boluda JC; Martínez-Trillos A; García-Gutiérrez V; Ferrer-Marín F; Xicoy B; Alvarez-Larrán A; Kerguelen A; Barba P; Gómez M; Herrera JC; Correa JG; Cervantes F
Leuk Lymphoma; 2016; 57(1):120-4. PubMed ID: 25944376
[TBL] [Abstract][Full Text] [Related]
27. Janus Kinase Inhibitors and Stem Cell Transplantation in Myelofibrosis.
El Fakih R; Popat U
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S34-42. PubMed ID: 26297276
[TBL] [Abstract][Full Text] [Related]
28. Splenectomy for severe autoimmune cytopenias after allogenic stem cell transplantation: case report.
Proleznik I; Prentice HG; Pretnar J; Zver S; Cernelc P
Int J Hematol; 2005 Jul; 82(1):75-8. PubMed ID: 16229090
[TBL] [Abstract][Full Text] [Related]
29. [Idiopathic myelofibrosis in internal medicine].
García-Gutiérrez V; Redondo S; Ruedas A
Med Clin (Barc); 2014 Dec; 143(11):498-501. PubMed ID: 25088655
[No Abstract] [Full Text] [Related]
30. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs.
Scotch AH; Kosiorek H; Scherber R; Dueck AC; Slot S; Zweegman S; Boekhorst PAWT; Commandeur S; Schouten H; Sackmann F; Fuentes AK; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Döhner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Paoli C; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Birgegard G; Xiao Z; Xu Z; Zhang Y; Sun X; Xu J; Kiladjian JJ; Zhang P; Gale RP; Mesa RA; Geyer HL
Leuk Res; 2017 Dec; 63():34-40. PubMed ID: 29096334
[TBL] [Abstract][Full Text] [Related]
31. Management of Myelofibrosis-Related Cytopenias.
Bose P; Verstovsek S
Curr Hematol Malig Rep; 2018 Jun; 13(3):164-172. PubMed ID: 29796726
[TBL] [Abstract][Full Text] [Related]
32. Novel treatments to tackle myelofibrosis.
Zimran E; Keyzner A; Iancu-Rubin C; Hoffman R; Kremyanskaya M
Expert Rev Hematol; 2018 Nov; 11(11):889-902. PubMed ID: 30324817
[TBL] [Abstract][Full Text] [Related]
33. Does anything work for anaemia in myelofibrosis?
Birgegård G
Best Pract Res Clin Haematol; 2014 Jun; 27(2):175-85. PubMed ID: 25189728
[TBL] [Abstract][Full Text] [Related]
34. Myelofibrosis with myeloid metaplasia.
Barosi G
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1211-26. PubMed ID: 14560783
[TBL] [Abstract][Full Text] [Related]
35. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic myelofibrosis: historical review, diagnosis and management.
Weinstein IM
Blood Rev; 1991 Jun; 5(2):98-104. PubMed ID: 1912760
[TBL] [Abstract][Full Text] [Related]
37. Correction of recurrent angioedema related to C1 esterase inhibitor deficiency as a secondary event following nonmyeloablative allogeneic stem cell transplantation in a patient with myelofibrosis.
Kiss TL; Messner HA; Galal A; Lipton J
Bone Marrow Transplant; 2005 Jan; 35(2):213-4. PubMed ID: 15531899
[No Abstract] [Full Text] [Related]
38. Myelofibrosis and myeloid leukaemia.
Krasilnikoff PA
Acta Paediatr Scand; 1967 Jul; 56(4):424-9. PubMed ID: 5232027
[No Abstract] [Full Text] [Related]
39. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
Dupriez B; Demory JL
Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
[TBL] [Abstract][Full Text] [Related]
40. Assessing new therapies and their overall impact in myelofibrosis.
Mesa RA
Hematology Am Soc Hematol Educ Program; 2010; 2010():115-21. PubMed ID: 21239780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
